Adonis · 16 hours ago
Business Development Representative
Adonis is the leading AI Orchestration platform for healthcare payments, seeking to transform revenue operations for healthcare organizations. The Business Development Representative will proactively seek and develop relationships with potential customers, qualifying leads to support the sales team in building a robust pipeline.
Artificial Intelligence (AI)Health CareInformation TechnologySoftware
Responsibilities
Proactively seek and research new business opportunities in the market and contact potential leads through cold calls, emails, LinkedIn messaging, social selling, and other best-in-class modes of outreach
Act as a subject matter expert on Adonis and our product offerings
Educate and nurture leads until they are qualified and ready to speak with an Account Executive according to our qualification criteria
Build trust and work with Account Executives to create an outbound strategy and drive pipeline
Follow-up on inbound leads and provide appropriate information to foster lead relationships
Qualification
Required
Minimum of One year of experience in a high-growth startup environment, large scale B2B orgs or health tech company
Self-motivated and target driven, with a strong desire to succeed in a fast-paced, high-growth environment
Team player with an entrepreneurial spirit who likes to try new ideas in order to achieve greater levels of success
Ability to operate with a strong sense of urgency and deliver results
Possess strong prioritization skills
Naturally and highly curious
Benefits
Competitive Equity Packages
Employer paid medical insurance
Employer paid dental insurance
Employer paid vision insurance
Employer funded HSA
Parental Leave
Commuter Benefits
Office Lunches Everyday
Office Snacks
Generous PTO
Company
Adonis
Adonis is a revenue intelligence and automation platform built for healthcare that improve critical RCM outcomes.
Funding
Current Stage
Growth StageTotal Funding
$53.9MKey Investors
Point72 VenturesGeneral CatalystBling Capital
2024-06-25Series B· $31M
2023-05-17Series A· $17.3M
2022-10-14Seed· $5.6M
Recent News
Morningstar.com
2025-11-27
2025-09-26
Company data provided by crunchbase